Table 2.
Allele (number of CAG repeats) | Num. of alleles in varicocele patients |
Number of alleles in controls | P- valuea | ||||
---|---|---|---|---|---|---|---|
Grade I | Grade II | Grade III | Total | ||||
8 | 0 | 0 | 0 | 0 (0%) | 0 (0%) | - | |
9 | 1 | 3 | 1 | 5 (6.25%) | 3 (4.8%) | 0.7322 | |
10 | 29 | 21 | 14 | 62 (77.5%) | 54 (83.8%) | 0.6425 | |
11 | 2 | 2 | 7 | 11 (13.75%) | 4 (13%) | 0.2047 | |
12 | 0 | 0 | 2 | 2 (2.5%) | 0 (0%) | 0.2156 | |
Genotype | Number of varicocele patients | Number of controls | |||||
Grade I | Grade II | Grade III | Total | ||||
10/10 Homozygous | 12 | 8 | 3 | 23 (57.5%) | 21 (70%) | 0.6107 | |
10 /≠10 Heterozygous | 3 | 5 | 8 | 16 (40%) | 9 (30%) | 0.5497 | |
≠10/≠10 Homozygous + Heterozygous | 0 | 0 | 1 | 1 (2.5%) | 0 (0%) | 0.3890 | |
Num. of samples | 15 | 13 | 12 | 40 | 30 |
a: Difference between varicocele and control group